ES426414A1 - Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding) - Google Patents

Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES426414A1
ES426414A1 ES426414A ES426414A ES426414A1 ES 426414 A1 ES426414 A1 ES 426414A1 ES 426414 A ES426414 A ES 426414A ES 426414 A ES426414 A ES 426414A ES 426414 A1 ES426414 A1 ES 426414A1
Authority
ES
Spain
Prior art keywords
weight
translation
preparation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES426414A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kohjin Holdings Co Ltd
Kohjin Co
Original Assignee
Kohjin Holdings Co Ltd
Kohjin Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Holdings Co Ltd, Kohjin Co filed Critical Kohjin Holdings Co Ltd
Publication of ES426414A1 publication Critical patent/ES426414A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Method for producing a freeze-dried cyclocytidine preparation, characterized in that it comprises preparing an aqueous solution containing cyclocytidine and at least one member selected from the group consisting of (1) a saccharide, (2) polyvinylpyrrolidone, (3) sodium carboxymethylcellulose and (4) a nonionic surfactant, the amount of said components (1), (2) and (3) being from about 0.1% by weight to about 5% by weight relative to the weight of said cyclocytidine and the amount being of said component (4) of about 0.01% by weight to about 0.05% by weight relative to the weight of said cyclocytidine, and freeze said aqueous solution. (Machine-translation by Google Translate, not legally binding)
ES426414A 1973-05-17 1974-05-17 Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding) Expired ES426414A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5414573A JPS5637967B2 (en) 1973-05-17 1973-05-17

Publications (1)

Publication Number Publication Date
ES426414A1 true ES426414A1 (en) 1976-07-01

Family

ID=12962379

Family Applications (1)

Application Number Title Priority Date Filing Date
ES426414A Expired ES426414A1 (en) 1973-05-17 1974-05-17 Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding)

Country Status (4)

Country Link
JP (1) JPS5637967B2 (en)
DE (1) DE2423811A1 (en)
ES (1) ES426414A1 (en)
FR (1) FR2229416A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
DE2658406C2 (en) * 1975-12-31 1984-04-26 Asahi Kasei Kogyo K.K., Osaka Process for the production of water-soluble pharmaceutical preparations containing N → 4 → -acylcytosine arabinoside
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
ID21635A (en) * 1996-12-20 1999-07-08 Astra Pharma Prod PHARMACEUTICAL COMPOSITION FOR FROZEN DRYING
KR0181252B1 (en) * 1996-12-31 1999-03-20 박원훈 Porous matrix sustained-release preparation by emulsion metho
CA2280130C (en) * 1997-02-05 2007-12-18 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
SE9702680D0 (en) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation

Also Published As

Publication number Publication date
JPS5637967B2 (en) 1981-09-03
DE2423811A1 (en) 1974-12-05
FR2229416A1 (en) 1974-12-13
JPS505523A (en) 1975-01-21

Similar Documents

Publication Publication Date Title
BE777107A (en) PROCESS FOR PREPARING ENZYMATIC COMPOSITIONS IN SPHERICAL FORM
MX6015E (en) PROCEDURE FOR THE PREPARATION OF HIGHLY STABILIZED IMMUNE SERUM GLOBULIN COMPOSITIONS
ES433908A1 (en) Pharmaceutical compositions and their preparation
NZ192046A (en) Cementitious composition comprising an acid formate of ammonium, sodium or potassium as an accelerator
ES426414A1 (en) Method to produce a preparation of dry cyclycytden by freezing. (Machine-translation by Google Translate, not legally binding)
SE8004043L (en) TOBACCO COMPOSITION
ES431758A1 (en) Method to produce a preparation of dry cyclicystine salt by freezing. (Machine-translation by Google Translate, not legally binding)
ES454147A1 (en) Procedure for preparing a particulate sazonant material. (Machine-translation by Google Translate, not legally binding)
ES394902A1 (en) Detergent compositions
ES406085A1 (en) Detergent compositions
ES374392A1 (en) Effervescent dye compositions
JPS51136689A (en) Process for preparing trithiane compounds
JPS545097A (en) Preparation of immobilized glucose isomerase
JPS52139789A (en) Method of preparing stable powder of neocarzinostatin
ES422688A1 (en) Procedure for the preparation of anti-pellowing products. (Machine-translation by Google Translate, not legally binding)
JPS5279090A (en) Preparation of powdered soy sauce
JPS5315344A (en) Preparation of 5-cyclohexadecene-1-one
JPS53104456A (en) Compression system refrigerator
JPS5247913A (en) Method of preparing concentrated and stable inosine solution
JPS5571702A (en) Antitumorous glucan derivative, its preparation, and carcinostatic substance containing it
ES422155A1 (en) Process for preparing 2,2{40 -anhydro-1{62 -D-arabi nofuranosyl-5-fluorocytosine and salts
JPS52105280A (en) Preparation of nucleicacidase
JPS51141852A (en) Process for preparing 1-alkyl-2-naphthols
JPS53113033A (en) Antihyperlipemics
JPS5386024A (en) Nonmedical fungicides